Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
- 17 October 2011
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 39 (6), 1425-1431
- https://doi.org/10.1183/09031936.00145411
Abstract
Resistance to anti-tuberculosis (TB) medicines is a major public health threat in most countries of the former Soviet Union. As no representative and quality-assured information on the magnitude of this problem existed in Belarus, a survey was conducted in the capital city of Minsk. Between November 2009 and December 2010, 156 consecutively diagnosed new and 68 previously treated culture-positive TB patients residing in Minsk were enrolled in the survey. Mycobacterium tuberculosis isolates were obtained from each patient and tested for susceptibility to first- and second-line anti-TB drugs. Multidrug-resistant (MDR)-TB was found in 35.3% (95% CI 27.7-42.8) of new patients and 76.5% (95% CI 66.1-86.8) of those previously treated. Overall, nearly one in two patients enrolled had MDR-TB. Extensively drug-resistant TB was reported in 15 of the 107 MDR-TB patients (14.0%, 95% CI 7.3-20.7). Patients 35 yrs. The findings of this survey in Minsk city are alarming and represent the highest proportions of MDR-TB ever recorded in the world. This study greatly contributes to the understanding of the burden of drug-resistant TB in urban areas of Belarus.Keywords
This publication has 13 references indexed in Scilit:
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateEuropean Respiratory Journal, 2011
- Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.2011
- Extensively drug-resistant tuberculosis: back to the futureEuropean Respiratory Journal, 2010
- Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004European Respiratory Journal, 2010
- Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance SurveillanceThe Lancet, 2009
- Epidemiology and clinical management of XDR-TB: a systematic review by TBNETEuropean Respiratory Journal, 2009
- Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TBEuropean Respiratory Journal, 2009
- Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?2008
- Clinical and operational value of the extensively drug-resistant tuberculosis definitionEuropean Respiratory Journal, 2007
- Evaluation of MGIT 960-Based Antimicrobial Testing and Determination of Critical Concentrations of First- and Second-Line Antimicrobial Drugs with Drug-Resistant Clinical Strains of Mycobacterium tuberculosisJournal of Clinical Microbiology, 2006